Atea Pharmaceuticals
AVIR
#7427
Rank
S$0.39 B
Marketcap
$4.65
Share price
1.74%
Change (1 day)
17.70%
Change (1 year)

Earnings for Atea Pharmaceuticals (AVIR)

Earnings in 2024 (TTM): -S$0.24 Billion

According to Atea Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$0.18 Billion a decrease over its 2022 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atea Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.24 Billion31.66%
2023 -S$0.18 Billion12.92%
2022 -S$0.16 Billion-186.22%
2021 S$0.18 B-1366.01%
2020 -S$14.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.17 Billion-28.49%๐Ÿ‡บ๐Ÿ‡ธ USA